Company: CRNX
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057452
Chunk: 37

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 37
---
,082 |     |               |  4.6 | % |

* Less than 1%. (1) Consists of 9,631,637.83 shares of common stock. FMR, LLC and Abigail P. Johnson have sole dispositive power with respect to all of the shares, and FMR, LLC has sole voting power with respect to 9,629,220 of the shares. The principal business address for FMR, LLC and Abigail P. Johnson is 245 Summer Street, Boston, Massachusetts 02210. Information

<div align='center'>24</div>

regarding these shares is based solely on the Schedule 13G/A filed on February 6, 2025 by FMR, LLC and Abigail P. Johnson.

Consists of 9,311,600 shares of common stock. The Vanguard Group has sole dispositive power over 9,092,816 of the shares and sole voting power over none of the shares. The address for The Vanguard Group is 100 Vanguard Blvd. Malvern, PA 19355. Information regarding these shares is based solely on the Schedule 13G/A filed on April 7, 2025 by The Vanguard Group.

Consists of 6,950,567 shares of common stock. Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP (“Wellington”) have sole dispositive power and sole voting power with respect to none of the shares. The address for Wellington is c/o Wellington Management Company LLP, 280 Congress Street, Boston MA 02210. Information regarding these shares is based on the Schedule 13G/A filed on February 10, 2025 by Wellington.

Consists of 4,944,757 shares of common stock. T. Rowe Price Associates, Inc. has sole dispositive power over 4,944,757of the shares and sole voting power over 4,854,723 of the shares. The address for T. Rowe Price Associates, Inc. is 100 E. Pratt Street, Baltimore, MD 21202. Information regarding these shares is based solely on the Schedule 13G/A filed on September 30, 2024 by T. Rowe Price Associates, Inc.

Includes (i) 891,805 shares of common stock held by various family trusts of which Dr. Struthers is the trustee or investment advisor, (ii) 410,417 shares of common stock held directly by Dr. Struthers